![](https://dblp1.uni-trier.de/img/logo.ua.320x120.png)
![](https://dblp1.uni-trier.de/img/dropdown.dark.16x16.png)
![](https://dblp1.uni-trier.de/img/peace.dark.16x16.png)
Остановите войну!
for scientists:
![search dblp search dblp](https://dblp1.uni-trier.de/img/search.dark.16x16.png)
![search dblp](https://dblp1.uni-trier.de/img/search.dark.16x16.png)
default search action
"Clinical trials, progression-speed differentiating features and swiftness ..."
Ying Hong Li et al. (2020)
- Ying Hong Li
, Xiao Xu Li, Jiajun Hong, Yunxia Wang
, Jianbo Fu
, Hong Yang, Chun Yan Yu, Feng Cheng Li
, Jie Hu
, Weiwei Xue
, Yu Yang Jiang, Yuzong Chen, Feng Zhu
:
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs. Briefings Bioinform. 21(2): 649-662 (2020)
![](https://dblp1.uni-trier.de/img/cog.dark.24x24.png)
manage site settings
To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.